- 2022 - 2025 Significance of Apg-2 in human NAFLD
- 2017 - 2020 分子シャペロンAPG-2による非アルコール性脂肪性肝疾患の制御と、その機序に基づく疾患予後評価法、治療法の開発
- 2015 - 2018 熱ショック蛋白APG-2の肝脂肪化と肝発癌誘導機序の解析
- 2013 - 2016 Examination about the association between intrahepatic immunogenicity and the expression of regulatory molecules on hepatic T cells in mouse NASH model.
- 2012 - 2015 肝癌の増殖と肝再生におけるApg-2の意義
- 2008 - 2010 The effect of DGAT on liver steatosis, fibrosis and carcinogenesis in murine NASH models.
- 2008 - 2010 Analysis of newly recognized amplified region in 1q21p in hepatocellular carcinoma
- 2006 - 2007 Investigation for the mechanisms of metastasis and growth of HCC via chemokine receptors
- 2005 - 2006 B型肝炎ウイルスのコードするmicroRNAの検索
- 2003 - 2004 HCV core蛋白を標的とした新たな遺伝子治療戦略の可能性
- 2003 - 2004 Analysis of chemokine/chemokine system involoved in the growth of human hepatocellular carcinoma
- 2001 - 2002 Gene transfer to hematopoietic stem cells by a newly-designed retroviral vectors and expression of transgenes in the liver
- 2000 - 2001 Expression of heparanase in the hepatic tissue of hepatitis patients and its clinical significance
- 1999 - 2000 肝細胞で高発現する新しいレトロウイルスベクターの開発
- 1998 - 1999 Expression of CXC chemokines lacking ELR-motif in liver diseases and its clinical significance
- 1998 - 1999 Treatment of chronic hepatitis and analysis of HBV integration for the purpose of prevention of hepatocellular carcinoma
- 1996 - 1996 C型肝炎での炎症性サイトカインの意義
- 1995 - 1995 肝炎患者でのC-Cケモカインの意義
- 1994 - 1994 肝炎患者末梢血の内因性インターフェロンαによる炎症性サイトカイン産生の制御
- 1993 - 1993 肝炎患者の肝組織中と末梢血探求におけるマクロファージコロニー刺激因子の臨床的意義
Show all